192 related articles for article (PubMed ID: 32815117)
21. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation.
Tsukamoto Y; Futani H; Kihara T; Watanabe T; Kumanishi S; Matsuo S; Hirota S; Ueda T; Yamamoto H; Yoshiya S
Pathol Res Pract; 2018 Sep; 214(9):1504-1509. PubMed ID: 29970305
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):998-1007. PubMed ID: 33611700
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Nakatani F; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):400-407. PubMed ID: 34775549
[TBL] [Abstract][Full Text] [Related]
24. Biological characteristics of a novel giant cell tumor cell line derived from spine.
Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Jul; 34(4):1266-1273. PubMed ID: 33990915
[TBL] [Abstract][Full Text] [Related]
26. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of a novel cell line, NCC-DDLPS2-C1, derived from a patient with dedifferentiated liposarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 May; 34(3):990-997. PubMed ID: 33555519
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome.
Ono T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Akiyama T; Sugaya J; Fukushima S; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Mar; 35(2):756-766. PubMed ID: 35118583
[TBL] [Abstract][Full Text] [Related]
30. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
[TBL] [Abstract][Full Text] [Related]
31. Symplastic/pseudoanaplastic giant cell tumor of the bone.
Sarungbam J; Agaram N; Hwang S; Lu C; Wang L; Healey J; Hameed M
Skeletal Radiol; 2016 Jul; 45(7):929-35. PubMed ID: 27020452
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy.
Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sugaya J; Kobayashi E; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Nov; 35(6):2011-2019. PubMed ID: 36103079
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
[TBL] [Abstract][Full Text] [Related]
35. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
[TBL] [Abstract][Full Text] [Related]
36. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
[TBL] [Abstract][Full Text] [Related]
37. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
39. Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Kobayashi E; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Cells; 2022 Jan; 11(2):. PubMed ID: 35053323
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
Balke M; Campanacci L; Gebert C; Picci P; Gibbons M; Taylor R; Hogendoorn P; Kroep J; Wass J; Athanasou N
BMC Cancer; 2010 Aug; 10():462. PubMed ID: 20799989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]